In this video, Dr. Mahul Amin of Labcorp and University of Tennessee provides an overview of the role AI is currently playing in the primary diagnosis of prostate cancer, and the value it brings to pathologists, physicians and patients. He also shares new data from robust precision and clinical validation studies conducted at multiple US and European laboratories as part of the FDA clearance, demonstrating AI’s clinical utility and benefits compared with the current standard of care.